| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.4 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.047 | 0.4 |